SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Dolby Laboratories, Inc. (DLB) trades at a trailing P/E of 23.9, forward P/E of 14.3. Trailing earnings yield is 4.18%, forward earnings yield 7.00%. PEG 0.22 (Peter Lynch undervalued ≤1.0). Graham Number is $39.31.
Criteria proven by this page:
- VALUE (51/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 14.3 (down from trailing 23.9) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.22 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 4.18% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 7.00% as earnings recover.
- Analyst consensus target $85.00 (+37.2% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 75/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
51/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DLB
Valuation Multiples
P/E (TTM)23.9
Forward P/E14.3
PEG Ratio0.22
Forward PEG0.22
P/B Ratio2.22
P/S Ratio4.32
EV/EBITDA13.6
Per Share Data
EPS (TTM)$2.52
Forward EPS (Est.)$4.34
Book Value / Share$27.26
Revenue / Share$14.02
FCF / Share$3.98
Yields & Fair Value
Earnings Yield4.18%
Forward Earnings Yield7.00%
Dividend Yield2.29%
Graham Number$39.31
SharesGrow IV$128.70 (+107.8%)
Analyst Target$85.00 (+37.2%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
29.4 |
5.15 |
2.78 |
5.33 |
0.89% |
| 2017 |
29.0 |
4.13 |
2.74 |
5.41 |
0.97% |
| 2018 |
171.6 |
-4.25 |
3.27 |
6.79 |
0.92% |
| 2019 |
25.7 |
0.23 |
2.85 |
5.29 |
1.18% |
| 2020 |
28.8 |
-3.44 |
2.74 |
5.74 |
1.33% |
| 2021 |
28.7 |
0.86 |
3.43 |
6.95 |
1.00% |
| 2022 |
35.4 |
-0.88 |
2.90 |
5.20 |
1.54% |
| 2023 |
37.8 |
4.35 |
3.22 |
5.84 |
1.36% |
| 2024 |
27.9 |
0.75 |
2.95 |
5.74 |
1.57% |
| 2025 |
27.2 |
-9.32 |
2.65 |
5.14 |
1.82% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$1.95 |
$1.08B |
$201.8M |
18.7% |
| 2018 |
$1.14 |
$1.17B |
$122.25M |
10.4% |
| 2019 |
$2.44 |
$1.24B |
$255.15M |
20.5% |
| 2020 |
$2.25 |
$1.16B |
$231.36M |
19.9% |
| 2021 |
$2.97 |
$1.28B |
$310.23M |
24.2% |
| 2022 |
$1.81 |
$1.25B |
$184.09M |
14.7% |
| 2023 |
$1.96 |
$1.01B |
$191.47M |
19% |
| 2023 |
$1.96 |
$1.3B |
$200.66M |
15.4% |
| 2024 |
$3.71 |
$1.27B |
$360.64M |
28.3% |
| 2025 |
$2.62 |
$1.35B |
$255.02M |
18.9% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$4.34 |
$4.31 – $4.37 |
$1.42B |
$1.41B – $1.43B |
3 |
| 2027 |
$4.63 |
$4.58 – $4.69 |
$1.47B |
$1.46B – $1.49B |
3 |
| 2028 |
$5.08 |
$5.03 – $5.15 |
$1.56B |
$1.54B – $1.57B |
1 |
